Assessment of lower extremity revascularization, CTO-percutaneous coronary intervention and ventricular septal defects in cardiovascular disease and obesity (2021)

Research Articlep. 93

FFR_CT-guided revascularization of silent coronary ischemia compared to best medical therapy following lower-extremity revascularization

Author(s): Gustavs Latkovskis, Edgars Zellans, Agate Krievina, Indulis Kumsars, Sanda Jegere, Andrejs Erglis, Christopher Zarins, Dainis Krievins

DOI: 10.37532/1755-5310.2021.13(s5).93

• Abstract
• Full-Text
• PDF

Review Articlep. 103

Prediction and assessment of the long-term outcomes of coronary chronic total occlusion-percutaneous coronary intervention

Author(s): Soichiro Ebisawa

DOI: 10.37532/1755-5310.2021.13(s5).103

• Abstract
• Full-Text
• PDF

Review Articlep. 109

Interventional device closure of perimembranous ventricular septal defects: challenges, pitfalls, and advancements in device technology

Author(s): Raymond N. HADDAD, Zakhia SALIBA

DOI: 10.37532/1755-5310.2021.13(s5).109

• Abstract
• Full-Text
• PDF

Review Articlep. 115

Cardiovascular diseases and obesity: The concise systematic review in the context of SARS-CoV-2

Author(s): Marcelo Melo Martins, Bernardo Pessoa de Assis, Danilo Lopes Assis, Max Paulo Pimentel de Jesus, Ericka Camara Ferreira da Rocha, Tiago Teixeira Correa de Barros, Violeta Gisella Bendezu Garcia, Jose Mauricio de Vasconcellos Neto Segundo, Neli Dalva Matheus, Eliana Migliorini Mustafa, Idiberto Jose Zotarelli Filho

DOI: 10.37532/1755-5310.2021.13(s5).115

• Abstract
• Full-Text
• PDF

Mini Reviewp. 120

The association of coronary artery disease and advanced glycation end-products

Author(s): Craig Basman, Sarah L Fishman, Varinder Singh, Leonid Poretsky

DOI: 10.37532/1755-5310.2021.13(s5).120

• Abstract
• Full-Text
• PDF